Volume 30, Supplement - Infectious Diseases and Carceral Health
SUPPLEMENT ISSUE
Outbreaks and Investigations
Outbreak of Invasive Serratia marcescens among Persons Incarcerated in a State Prison, California, USA, March 2020–December 2022
Amanda Kamali
, Donna Ferguson, Heather Dowless, Nancy Ortiz, Rituparna Mukhopadhyay, Cassandra Schember, Rawni Lunsford, Justine Hutchinson, Marlena Scherer, John Crandall, Heidi Bauer, Alexander Yu, and Akiko Kimura
, Donna Ferguson, Heather Dowless, Nancy Ortiz, Rituparna Mukhopadhyay, Cassandra Schember, Rawni Lunsford, Justine Hutchinson, Marlena Scherer, John Crandall, Heidi Bauer, Alexander Yu, and Akiko Kimura
Table 1
Demographic data and other characteristics of 21 patients infected with invasive Serratia marcescens at prison A, California, USA, 2020–2022*
| Characteristic | Value |
|---|---|
| Median age, y (range) |
44 (22–66) |
| Race and ethnicity | |
| White | 9 (43) |
| Black | 2 (10) |
| Hispanic | 8 (38) |
| Other |
2 (10) |
| Serratia diagnosis† | |
| Bacteremia | 11 (52) |
| Endocarditis | 2 (10) |
| Epidural abscess | 9 (43) |
| Osteomyelitis | 6 (29) |
| Pseudoaneurysm | 1 (5) |
| Severe soft tissue infection |
4 (19) |
| Type of injection drug used,† n = 21 | |
| Heroin | 18 (86) |
| Suboxone | 12 (57) |
| Methamphetamine | 8 (38) |
| Opiates (by hospital urine toxicology screen) | 5 (24) |
*Values are no. (%) patients except as indicated. †Not mutually exclusive.
Page created: October 12, 2023
Page updated: March 31, 2024
Page reviewed: March 31, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.